Literature DB >> 16532430

ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats.

I Hamming1, G Navis, M J A Kocks, H van Goor.   

Abstract

Angiotensin-converting enzyme inhibitors (ACEi) provide renoprotection. A low sodium diet enhances their efficacy. However, the added effect of sodium restriction on proteinuria and blood pressure is not invariably associated with better preservation of renal morphology, suggesting that the combination of ACEi with a low sodium diet can elicit renal structural abnormalities. To test this hypothesis, the effects of ACEi in combination with a control (CS) or a low sodium (LS) diet were investigated in healthy rats and in adriamycin nephrotic rats. After 3 weeks of treatment, rats were sacrificed and kidneys examined for renal structural abnormalities. In healthy rats, ACEi reduced blood pressure: the fall in blood pressure was significantly greater in the ACEi/LS group. Renal morphology was normal in the ACEi/CS group but severe interstitial damage was found in the ACEi/LS group. This was associated with increased interstitial macrophage influx and up-regulation of osteopontin, alpha-smooth muscle actin, and collagen III expression. In addition, ACEi/LS induced an increase in the total medial area of afferent arterioles. In nephrotic rats, ACEi/LS reduced both blood pressure and proteinuria, whereas only blood pressure was reduced in the ACEi/CS group. Mild interstitial damage was present in the ACEi/CS group but, strikingly, pronounced tubulo-interstitial abnormalities occurred in the ACEi/LS group, similar to those seen in ACEi/LS healthy rats, with similar changes in afferent arteriolar walls. In conclusion, the combination of ACEi/LS elicits pronounced renal interstitial abnormalities in healthy and nephrotic rats, despite a significant reduction of proteinuria in the latter. Considering their occurrence in healthy rats, these renal adverse effects cannot be due to specific characteristics of adriamycin nephrosis. Further studies should elucidate the mechanisms underlying these observations and their impact on long-term renoprotection. Copyright 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16532430     DOI: 10.1002/path.1956

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  13 in total

Review 1.  Improving the efficacy of RAAS blockade in patients with chronic kidney disease.

Authors:  Hiddo J Lambers Heerspink; Martin H de Borst; Stephan J L Bakker; Gerjan J Navis
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

2.  Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Kaleab Z Abebe; Robert W Schrier; Ronald D Perrone; Arlene B Chapman; Alan S Yu; William E Braun; Theodore I Steinman; Godela Brosnahan; Marie C Hogan; Frederic F Rahbari; Jared J Grantham; Kyongtae T Bae; Charity G Moore; Michael F Flessner
Journal:  Kidney Int       Date:  2016-12-16       Impact factor: 10.612

3.  Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.

Authors:  Femke Waanders; Vishal S Vaidya; Harry van Goor; Henri Leuvenink; Kevin Damman; Inge Hamming; Joseph V Bonventre; Liffert Vogt; Gerjan Navis
Journal:  Am J Kidney Dis       Date:  2008-09-27       Impact factor: 8.860

4.  Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.

Authors:  Liffert Vogt; Femke Waanders; Frans Boomsma; Dick de Zeeuw; Gerjan Navis
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

Review 5.  Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism.

Authors:  Carolina R C Doorenbos; Jacob van den Born; Gerjan Navis; Martin H de Borst
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

Review 6.  Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease.

Authors:  Fouad T Chebib; Vicente E Torres
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-26       Impact factor: 8.237

7.  ACE Inhibition in Anti-Thy1 Glomerulonephritis Limits Proteinuria but Does Not Improve Renal Function and Structural Remodeling.

Authors:  Peter E Westerweel; Jaap A Joles; Krista den Ouden; Roel Goldschmeding; Maarten B Rookmaaker; Marianne C Verhaar
Journal:  Nephron Extra       Date:  2012-01-26

8.  Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.

Authors:  Saleh Yazdani; Ryanne S Hijmans; Fariba Poosti; Wendy Dam; Gerjan Navis; Harry van Goor; Jacob van den Born
Journal:  Dis Model Mech       Date:  2015-05-14       Impact factor: 5.758

9.  Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis.

Authors:  Katarina Mirković; Carolina R C Doorenbos; Wendy A Dam; Hiddo J Lambers Heerspink; Maartje C J Slagman; Ferdau L Nauta; Andrea B Kramer; Ronald T Gansevoort; Jacob van den Born; Gerjan Navis; Martin H de Borst
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

Review 10.  Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease.

Authors:  Jelmer K Humalda; Gerjan Navis
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.